Literature DB >> 29285513

Radiation risk from lung cancer screening.

Cristiano Rampinelli1, Paolo De Marco2, Massimo Bellomi1.   

Abstract

Entities:  

Year:  2017        PMID： 29285513      PMCID： PMC5733323          DOI： 10.21037/atm.2017.09.04

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  4 in total

1.  Model-based iterative reconstruction technique for ultralow-dose computed tomography of the lung: a pilot study.

Authors:  Yoshitake Yamada; Masahiro Jinzaki; Yutaka Tanami; Eisuke Shiomi; Hiroaki Sugiura; Takayuki Abe; Sachio Kuribayashi
Journal:  Invest Radiol       Date:  2012-08       Impact factor: 6.016

2.  Low-dose radiation risk extrapolation fallacy associated with the linear-no-threshold model.

Authors:  Bobby R Scott
Journal:  Hum Exp Toxicol       Date:  2008-02       Impact factor: 2.903

3.  Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.

Authors:  Cristiano Rampinelli; Paolo De Marco; Daniela Origgi; Patrick Maisonneuve; Monica Casiraghi; Giulia Veronesi; Lorenzo Spaggiari; Massimo Bellomi
Journal:  BMJ       Date:  2017-02-08

4.  Radiation dose reduction for CT lung cancer screening using ASIR and MBIR: a phantom study.

Authors:  Kelsey B Mathieu; Hua Ai; Patricia S Fox; Myrna Cobos Barco Godoy; Reginald F Munden; Patricia M de Groot; Tinsu Pan
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102
  4 in total
  2 in total

Review 1.  Focus on lung cancer screening.

Authors:  Alfredo Tartarone; Rosa Lerose; Michele Aieta
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 3.005

2.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.